This 2015 prospective single-arm study evaluated the efficacy of intra-articular dextrose prolotherapy in 24 female patients (mean age 58.4 years) with moderate knee osteoarthritis. Patients received three injections of 20% dextrose at baseline, 4 weeks, and 8 weeks. Outcomes measured over 24 weeks included pain (VAS), range of motion (ROM),
